DB18404InvestigationalGene Therapies
Cotsiranib: Overview.
- Also known as
- STP705 (small interfering RNA (siRNA) therapeutic directed against transforming growth factor-beta 1 (TGF-beta 1) and cyclo-oxygenase-2 (COX-2))
- Code names
- STP-705
Resolves to
Compound
What you can answer from here — as of April 23, 2025
Which companies are running trials of Cotsiranib, in which indications and phases, and which of those programs are still active?
Create a free account or log in to explore the full data card.
Create Account